Primary Health Properties posts strong interim results on Assura deal
(Alliance News) - Primary Health Properties PLC on Thursday delivered a strong interim financial performance, as the healthcare facility investor remained focused on integrating Assura PLC.
The London-based healthcare facility investor completed its acquisition of Assura in October last year, with synergies substantially achieved at the end of June 30.
For the six months that ended June 30, pretax profit surged 61% to GBP100 million from GBP62 million a year earlier.
Net rental income more than doubled to GBP176 million from GBP79 million, boosted by the addition of Assura. The occupancy rate held steady at 99%, compared to December 31.
PHP lifted its interim dividend to 3.65 pence, up 2.8% from 3.55p.
Earnings per share declined 14% to 3.8p from 4.4p, while headline EPS was flat at 3.2p.
As at June 30, net tangible assets per share was 99p, up 1.0% from 98p at December 31 but down 4.8% from 104.0p a year before.
PHP said it had delivered another "strong" operational and financial performance, with a focus on driving rental growth from its existing assets.
It said its immediate focus remains on delivering the strategic benefits and priorities following the combination with Assura.
Annualised synergies of GBP9 million identified at the time of the combination had been substantially delivered, PHP said.
PHP believes that it will continue to drive future rental growth, as evidenced through opportunities in its asset management and development pipelines.
Shares in PHP were up 0.4% to 97.05p on Thursday afternoon in London. They were up much more significantly in Johannesburg, rising 7.6% to ZAR21.53.
By Artwell Dlamini, Alliance News senior reporter South Africa
Comments and questions to newsroom@alliancenews.com
Copyright 2026 Alliance News Ltd. All Rights Reserved.
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
5 Stocks to Buy Trading at Big Discounts
2 Undervalued Stocks to Buy With Long-Term Growth Ahead
The Market May Be Too Pessimistic About This 4-Star Dividend Stock
What 7 Key Market Indicators Are Telling Investors Right Now